ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 84 filers reported holding ODONATE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $9,051,000 | -99.9% | 213,770 | -53.5% | 0.07% | -40.2% |
Q1 2020 | $11,968,367,000 | -19.8% | 459,968 | 0.0% | 0.12% | +17.0% |
Q4 2019 | $14,925,962,000 | +124563.5% | 459,968 | 0.0% | 0.10% | +20.5% |
Q3 2019 | $11,973,000 | -29.1% | 459,968 | 0.0% | 0.08% | -28.4% |
Q2 2019 | $16,876,000 | – | 459,968 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 14,075,269 | $595,947,000 | 57.94% |
Samsara BioCapital, LLC | 496,505 | $21,022,000 | 6.76% |
Boxer Capital, LLC | 3,363,377 | $142,405,000 | 6.26% |
Opaleye Management Inc. | 250,000 | $10,585,000 | 2.14% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 785,913 | $33,276,000 | 0.81% |
RTW INVESTMENTS, LP | 481,027 | $20,367,000 | 0.57% |
Birchview Capital, LP | 20,000 | $847,000 | 0.51% |
Rock Springs Capital Management LP | 437,231 | $18,512,000 | 0.51% |
Redmile Group, LLC | 633,038 | $26,803,000 | 0.50% |
SABBY MANAGEMENT, LLC | 40,500 | $1,715,000 | 0.34% |